Pharmacoeconomics and Outcome Assessment - A Global Issue
Euromed Communications Ltd, January 1999, Pages: 168
Spurred on by requirements for pharmaceutical companies to demonstrate value for money from healthcare intervention, the pharmaceutical industry is having to increase its activities in the economic evaluation of medicines and quality of life assessment. To do this effectively and efficiently there is a need to train both marketing executives and clinical researchers in techniques of pharmacoeconomics.
This book shows the vital and increasing role pharmacoeconomics plays now and in the future of the pharmaceutical industry. Written by international experts in their fields, the book gives an invaluable insight into this new and exciting discipline. First published in 1999, the subject matter is still topical and may appeal to American companies affected by healthcare costs.
- Foreword by Professor Mike Drummond, University of York. The impact of health economics on health policy, health services and decision-making by Professor David Cohen, University of Glamorgan
- Pharmacoeconomics: what's in a name? by Professor Mo Malek, University of St Andrews
- Pharmacoeconomic education in schools of pharmacy by Professor David Sclar, Washington State University
- Methodologies used to evaluate and measure the economic outcomes of drug treatments by Clive Pritchard and Adrian Towse, Office of Health Economics, London
- Case studies in pharmacoeconomics and assessment of outcomes by Professor David Sclar, Washington State University
- The use of interactive computer models to present pharmacoeconomic data by Andy Duggan, Abacus International, Bicester
- Pharmacoeconomics and clinical drug research by Dr Jeff Lee, Applied Health Outcomes, Franklin
- The potential and limitations of pharmacoeconomic research in the pharmaceutical industry by Dr Ray Churnside, Pfizer, Sandwich and Patrick Hopkinson, GlaxoWellcome, Greenford
- The role of pharmacoeconomics in response to globalization and increased competition in the pharmaceutical industry by Dr Greg Hess, SmithKline Beecham, Collegeville
- Pharmacoeconomics and the future of the pharmaceutical industry. Should they be encouraged to establish a pharmacoeconomic team? by Dr David Jones, SmithKline Beecham, Welwyn Garden City
"a timely addition to the current literature ... it deserves to be on the shelves of industry executives - as well as students and academics."
- Review in Pharma pricing & reimbursement
"The book deals with issues at a level that the uninitiated can understand and the practicing pharmacoeconomist can relate to .... Sam Salek has achieved what he set out to do with this book; it is a valuable text for anyone wishing to delve in the world of pharmacoeconomics."
- Review in Pharma pricing & reimbursement
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
